A CHLA study found that the sickest babies with heterotaxy-associated heart disease often don't survive early surgery. Now the team is taking a new approach.
Hundreds of members of the research community gathered to discuss breakthroughs in understanding the biological drivers of cancer and to present new research projects.
CHLA’s Michael I. Goran, PhD, and colleagues led the study, which analyzed changes in blood sugar levels among infants fed with human milk, lactose-based formula, and corn syrup solids-based formula.
